Donguibogam Evidence Bridge한국어

Turmeric 薑黃

Pharmaceutical nameCurcumae Longae Rhizoma

Evidence grade: Promisingauto-proposed · unreviewedSafety signal: CautionMapping confidence: Strong correspondence

The three axes are assessed independently and are never combined into a single score.

KTKP records the origin species as Curcuma longa L.. It has not yet been cross-checked against the Korean Pharmacopoeia, so the identification confidence is not raised to an official code mapping. The same drug appears under 2 records as name variants. The same source species also yields 1 other separately registered drug(s) (Curcumae Radix), which must not be conflated. The name most used for this taxon in current literature is Curcuma longa. Literature searches for this herb also cover Curcuma domestica, Curcumae longae — the same taxon appears under several names.

Tradition · what the text describes

탕액편

The sub-section within this volume has not been verified against the original text yet.

The KTKP traditional materia medica record (M0000103) gives the origin species as Curcuma longa L., the part used as 뿌리줄기, and the properties as 무독(無毒), 신고(辛苦), 온(溫). It lists 간(肝), 비경(脾經) as the channels entered. The same record cites the Donguibogam (1613) as the source for its indications.

Properties & channel entry: 무독(無毒), 신고(辛苦), 온(溫) · 간(肝), 비경(脾經)

Source species: Curcuma longa L. (뿌리줄기)

Read the original: Korean Medicine Classics DB ↗

Modern · documented evidence

Breast Cancerevidence for this indication

Evidence grade: Promisingauto-proposed · unreviewed
  • The indication was derived automatically from the Condition field of 7 registered trial(s). It reflects what is currently being studied, not a traditional use, and a curator should confirm the label is apt.

Literature

SR 0 · RCT 2 · preclinical 35

0 systematic review(s) and 2 RCT(s) were found. Size and consistency are not yet assessed.

Query used

We publish the exact query behind these counts so you can reproduce them yourself.

SRC:MED AND ((TITLE_ABS:"Curcuma longa") OR (TITLE_ABS:"Curcuma domestica") OR (TITLE_ABS:"Curcumae longae")) AND TITLE_ABS:"Breast Cancer"

Clinical trials

Osteoarthritisevidence for this indication

Evidence grade: Establishedauto-proposed · unreviewed
  • An A grade requires checking that the conclusions are consistent. Read the abstracts — counts alone cannot establish an A.
  • The indication was derived automatically from the Condition field of 6 registered trial(s). It reflects what is currently being studied, not a traditional use, and a curator should confirm the label is apt.

Literature

SR 8 · RCT 15 · preclinical 17

8 systematic review(s) and 15 randomized controlled trial(s) were found.

Query used

We publish the exact query behind these counts so you can reproduce them yourself.

SRC:MED AND ((TITLE_ABS:"Curcuma longa") OR (TITLE_ABS:"Curcuma domestica") OR (TITLE_ABS:"Curcumae longae")) AND TITLE_ABS:"Osteoarthritis"

Clinical trials

Psoriasisevidence for this indication

Evidence grade: Promisingauto-proposed · unreviewed
  • The indication was derived automatically from the Condition field of 5 registered trial(s). It reflects what is currently being studied, not a traditional use, and a curator should confirm the label is apt.

Literature

SR 4 · RCT 1 · preclinical 11

4 systematic review(s) and 1 RCT(s) were found. Size and consistency are not yet assessed.

Query used

We publish the exact query behind these counts so you can reproduce them yourself.

SRC:MED AND ((TITLE_ABS:"Curcuma longa") OR (TITLE_ABS:"Curcuma domestica") OR (TITLE_ABS:"Curcumae longae")) AND TITLE_ABS:"Psoriasis"

Clinical trials

Safety

auto-proposed · unreviewed

  • This signal was read off the NCCIH text by keyword rules. A curator must read the source and confirm it.
  • The KTKP record states the following traditional contraindication: 혈허(血虛)로 기체혈어(氣滯血瘀)가 없는 자(者)는 복용(服用)을 기(忌)한다.
  • NCCIH states: · Oral turmeric can cause adverse effects such as nausea and vomiting, acid reflux, stomach upset, diarrhea, or constipation.
  • NCCIH states: · Many curcumin products with increased bioavailability are on the market, and liver damage has been reported in some people who have consumed these bioavailable formulations.
  • NCCIH states: If you notice any liver damage symptoms such as fatigue, nausea, poor appetite, dark urine, or jaundice, stop consuming turmeric or curcumin products immediately and talk with your health care provider.
  • NCCIH states: · The use of turmeric supplements during pregnancy may be unsafe.
  • NCCIH states: Little is known about whether it’s safe to use turmeric in amounts greater than those commonly found in food while breastfeeding.

Adverse-event and toxicity literature

This is not a finding of harm — it lists literature that is retrievable. Read the papers to decide.

Interaction literature

This lists literature that is retrievable — it is not a judgement that an interaction exists. Read the papers to decide.

Sources

Bridges from here

In formulas
침향강기산
Related patterns
Qi stagnation pattern